ZYNERBA PHARMACEUTICALS, INC. Diluted Shares Outstanding (Weighted Average)
ZYNERBA PHARMACEUTICALS, INC. reported Diluted Shares Outstanding (Weighted Average) of 50.15 million shares for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2023-08-14
- ZYNERBA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2023-06-30 was 50.15M shares, a 21.12% increase year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2023-03-31 was 48.43M shares, a 20.16% increase year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2022-12-31 was 45.16M shares, a 12.22% increase year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for the quarter ending 2022-09-30 was 43.75M shares, a 9.12% increase year-over-year.
- ZYNERBA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2022 was 42.66M shares, a 8.67% increase from fiscal 2021.
- ZYNERBA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2021 was 39.26M shares, a 45.28% increase from fiscal 2020.
- ZYNERBA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2020 was 27.02M shares, a 22.83% increase from fiscal 2019.
- ZYNERBA PHARMACEUTICALS, INC. weighted average number of shares outstanding, diluted for fiscal 2019 was 22.00M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2023-06-30 | 50.15M shares 10-Q · filed 2023-08-14 | 49.30M shares 10-Q · filed 2023-08-14 | 47.91M shares derived: average of 3 quarters · filed 2023-08-14 | 46.87M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 48.43M shares 10-Q · filed 2023-05-15 | 46.79M shares derived: average of 2 quarters · filed 2023-05-15 | 45.78M shares derived: average of 3 quarters · filed 2023-05-15 | 44.68M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-12-31 | 45.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | 44.45M shares derived: average of 2 quarters · filed 2023-03-28 | 43.44M shares derived: average of 3 quarters · filed 2023-08-14 | 42.66M shares 10-K · filed 2023-03-28 |
| 2022-09-30 | 43.75M shares 10-Q · filed 2022-11-14 | 42.58M shares derived: average of 2 quarters · filed 2023-08-14 | 41.83M shares 10-Q · filed 2022-11-14 | 41.42M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-06-30 | 41.41M shares 10-Q · filed 2023-08-14 | 40.86M shares 10-Q · filed 2023-08-14 | 40.65M shares derived: average of 3 quarters · filed 2023-08-14 | 40.51M shares derived: average of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | 40.30M shares 10-Q · filed 2023-05-15 | 40.27M shares derived: average of 2 quarters · filed 2023-05-15 | 40.21M shares derived: average of 3 quarters · filed 2023-05-15 | 40.18M shares derived: average of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | 40.24M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | 40.17M shares derived: average of 2 quarters · filed 2023-03-28 | 40.13M shares derived: average of 3 quarters · filed 2023-03-28 | 39.26M shares 10-K · filed 2023-03-28 |
| 2021-09-30 | 40.09M shares 10-Q · filed 2022-11-14 | 40.08M shares derived: average of 2 quarters · filed 2022-11-14 | 38.93M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 40.07M shares 10-Q · filed 2022-08-10 | 38.34M shares 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | 40.07M shares 10-Q · filed 2022-05-16 | |||
| 2020-12-31 | 27.02M shares 10-K · filed 2023-03-28 | |||
| 2019-12-31 | 22.00M shares 10-K · filed 2022-03-01 |